Concepedia

Megumi Kanasaki

MK

Statistics

Publications

15

Citations

1.1K

H-Index

14

Active since

2011

Affiliations

Kanazawa Medical University(Current)

Harvard University

Beth Israel Deaconess Medical Center

The University of Texas MD Anderson Cancer Center

Indiana University – Purdue University Indianapolis

Megumi Kanasaki is an author at Kanazawa Medical University specializing in medicine, life sciences, and diabetes mellitus.

Publications per year

2011–2020

15

Publications

15

Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen

Keizo Kanasaki, Sen Shi, Megumi Kanasaki et al. · Diabetes · 2014 · 368 citations · Full text

Medicine, Nephrology, Pharmacology +17

Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition

Sen Shi, Swayam Prakash Srivastava, Megumi Kanasaki et al. · Kidney International · 2015 · 157 citations

Life Sciences, Cell Biology, Molecular Biology +11

N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition

Takako Nagai, Megumi Kanasaki, Swayam Prakash Srivastava et al. · BioMed Research International · 2014 · 86 citations · Full text

Medicine, Biochemistry, Nephrology +17

Loss of p53 and Acquisition of Angiogenic MicroRNA Profile Are Insufficient to Facilitate Progression of Bladder Urothelial Carcinoma in Situ to Invasive Carcinoma

Francisco Ayala, Keizo Kanasaki, Megumi Kanasaki et al. · Journal of Biological Chemistry · 2011 · 68 citations · Full text

Medicine, Molecular Biology, Oncology +17

Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis

Swayam Prakash Srivastava, Sen Shi, Megumi Kanasaki et al. · Scientific Reports · 2016 · 67 citations · Full text

Medicine, Molecular Biology, Pathobiology +17

1–5 of 15